BackgroundCheck.run
Search For

Megan S Li, 36300 Berry St UNIT 1505, San Francisco, CA 94158

Known as:
Megan Sli S Limegan
Related to:
Hungwen Li Hung Li

Megan Li Phones & Addresses

300 Berry St UNIT 1505, San Francisco, CA 94158   

Saratoga, CA   

Get Report
Control this profile

Mentions for Megan S Li

Publications & IP owners

Us Patents

Antibody Formulation

US Patent:
2011022, Sep 22, 2011
Filed:
Dec 20, 2010
Appl. No.:
12/973640
Inventors:
Yatin R. Gokarn - Palo Alto CA, US
Timothy J. Kamerzell - Overland Park KS, US
Megan Li - San Francisco CA, US
Mary Cromwell - Redwood City CA, US
Hong Liu - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61B 19/02
A61K 39/395
A61P 35/00
A61P 27/02
A61P 3/10
A61P 13/12
A61P 19/02
A61P 9/10
A61P 17/06
A61P 11/06
US Classification:
206438, 4241301, 4241581, 4241451, 4241331
Abstract:
The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation

US Patent:
2020039, Dec 17, 2020
Filed:
Feb 21, 2020
Appl. No.:
16/798211
Inventors:
- South San Francisco CA, US
Timothy J. KAMERZELL - Overland Park KS, US
Megan LI - San Francisco CA, US
Mary CROMWELL - Redwood City CA, US
Hong LIU - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/22
A61K 9/00
A61K 39/395
A61K 47/18
A61K 47/26
A61K 47/22
A61J 1/20
A61J 1/14
Abstract:
The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation

US Patent:
2018017, Jun 21, 2018
Filed:
Jul 24, 2017
Appl. No.:
15/658306
Inventors:
- South San Francisco CA, US
Timothy J. KAMERZELL - Overland Park KS, US
Megan LI - San Francisco CA, US
Mary CROMWELL - Redwood City CA, US
Hong LIU - Foster City CA, US
International Classification:
C07K 16/22
A61K 47/18
A61J 1/14
A61K 9/00
A61K 47/26
A61K 47/22
A61J 1/20
A61K 39/395
A61K 39/00
Abstract:
The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation

US Patent:
2016025, Sep 1, 2016
Filed:
Nov 25, 2015
Appl. No.:
14/952551
Inventors:
- South San Francisco CA, US
Timothy J. KAMERZELL - Overland Park KS, US
Megan LI - San Francisco CA, US
Mary CROMWELL - Redwood City CA, US
Hong LIU - Foster City CA, US
International Classification:
C07K 16/22
A61J 1/20
A61J 1/14
Abstract:
The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation

US Patent:
2014009, Apr 10, 2014
Filed:
Oct 4, 2013
Appl. No.:
14/046909
Inventors:
- South San Francisco CA, US
Timothy J. Kamerzell - Overland Park KS, US
Megan Li - San Francisco CA, US
Mary Cromwell - Redwood City CA, US
Hong Liu - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395
A61K 47/22
A61K 47/18
US Classification:
4241331, 4241301, 4241451, 4241581, 206525
Abstract:
The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Possible Relatives

David X Li  Daming Li  Deng Li  Daqi Li  Diane P Li  Dong M Li  Eberle M Li  Megan S Johnson  Megan E White  Megan Jolly 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.